These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12217610)

  • 21. [A case of early uptake of hepatobiliary scan agent in hepatocellular carcinoma].
    Fujikawa M; Okazaki K; Miyao M; Miyazaki M; Onishi S; Ito K; Yoshida S; Nakasato J
    Rinsho Hoshasen; 1986 Jun; 31(6):749-52. PubMed ID: 3020277
    [No Abstract]   [Full Text] [Related]  

  • 22. Octreotide in hepatocellular carcinoma.
    Shouval D
    Gut; 1998 Mar; 42(3):316-7. PubMed ID: 9577332
    [No Abstract]   [Full Text] [Related]  

  • 23. Tc-99m MDP uptake in hepatoblastoma.
    Elgazzar AH; Jahan S; Motawei S; Abdel-Dayem HM
    Clin Nucl Med; 1989 Feb; 14(2):143. PubMed ID: 2543533
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatoma visualization with Tc-99m pyridoxylidene glutamate.
    Utz JA; Lull RJ; Anderson JH; Lambrecht RW; Brown JM; Henry W
    J Nucl Med; 1980 Aug; 21(8):747-9. PubMed ID: 6249896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The lung and mediastinal metastases of a hepatocellular carcinoma. Enhancement in the liver function scintigram with 99mTc-IODIDA].
    Link TM; Anger K; Hebestreit HP; Bade J
    Rofo; 1992 Jul; 157(1):101-2. PubMed ID: 1322200
    [No Abstract]   [Full Text] [Related]  

  • 26. PET scan with 11C-acetate for the imaging of liver masses: report of a false positive case.
    Lhommel R; Annet L; Bol A; Gigot JF; Sempoux C; Mathieu I; Seret M; Lonneux M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):629. PubMed ID: 15549295
    [No Abstract]   [Full Text] [Related]  

  • 27. The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.
    Borbath I; Horsmans Y
    Hepatology; 2003 Feb; 37(2):477-8; author reply 478. PubMed ID: 12575712
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angiography in benign hepatocellular tumors: focal nodular hyperplasia of the liver and hepatocellular adenoma (author's transl)].
    Minakuchi K; Yamada R; Nakatsuka H; Nakamura K; Minamikawa Y; Koike N
    Rinsho Hoshasen; 1979 Dec; 24(13):1487-91. PubMed ID: 230375
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic imaging by radioisotopes. Application (XI). Some considerations on radionuclide images of the liver].
    Oyamada H
    Radioisotopes; 1985 Aug; 34(8):456-65. PubMed ID: 2999884
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
    Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON
    Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.
    Samonakis DN; Christodoulakis N; Kouroumalis EA
    J Clin Gastroenterol; 2006 Jan; 40(1):86-7. PubMed ID: 16340641
    [No Abstract]   [Full Text] [Related]  

  • 32. Octreotide and hepatocellular carcinoma.
    Farinati F; Sergio A; Baldan A; Zucchetta P; Corleto VD
    Br J Cancer; 2007 Jun; 96(11):1778-9. PubMed ID: 17505506
    [No Abstract]   [Full Text] [Related]  

  • 33. [Assessment of liver function using 99mTc-GSA in patients with chronic liver disease and/or hepatocellular carcinoma before and after transcatheter arterial embolization].
    Kosuda S; Shioyama Y; Suzuki K; Hayashi S; Tanaka S
    Kaku Igaku; 1991 Nov; 28(11):1385-92. PubMed ID: 1663177
    [No Abstract]   [Full Text] [Related]  

  • 34. A rare case of hepatic carcinoid.
    Tagliabue L; Tarolo GL; Bestetti A; Di Leo C; Del Sole A
    Clin Nucl Med; 2001 Oct; 26(10):893. PubMed ID: 11564944
    [No Abstract]   [Full Text] [Related]  

  • 35. [67Ga-scintigraphy in patients with primary and secondary hepatic malignant neoplasms].
    Ozawa M; Jinnouchi M; Hoshi H; Harada K; Nagamachi S; Onoe K; Mori N; Watanabe K
    Rinsho Hoshasen; 1986 Aug; 31(8):907-11. PubMed ID: 3022042
    [No Abstract]   [Full Text] [Related]  

  • 36. Uptake of hepatobiliary agents by hepatocellular carcinoma.
    Vincent LM; Renner JB
    AJR Am J Roentgenol; 1984 Nov; 143(5):1119-21. PubMed ID: 6091431
    [No Abstract]   [Full Text] [Related]  

  • 37. Computed tomography of hepatocellular carcinoma.
    Kunstlinger F; Federle MP; Moss AA; Marks W
    AJR Am J Roentgenol; 1980 Mar; 134(3):431-7. PubMed ID: 6243845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of scintigraphies with 99mTc-phytate and 67Ga-citrate as a screening test for hepatocellular carcinoma (author's transl)].
    Ayabe Y; Oshiumi Y; Kamoi I; Ichiya Y; Murakami J; Nagasue N; Inoguchi K; Matsuura K
    Kaku Igaku; 1981 Feb; 18(1):41-8. PubMed ID: 6268876
    [No Abstract]   [Full Text] [Related]  

  • 39. Value of hepatic blood flow study in the diagnosis of hepatoma.
    Lee HK; Skarzynski J; Kim U
    Mt Sinai J Med; 1989 Jan; 56(1):33-5. PubMed ID: 2537923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation.
    Casarella WJ; Knowles DM; Wolff M; Johnson PM
    AJR Am J Roentgenol; 1978 Sep; 131(3):393-402. PubMed ID: 210643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.